thank stand welcome west pharmaceutical service earn conference call operator instruction please advise today conference call record operator instruction would like hand conference vice president investor relation please ahead vice president investor relation thank good morning welcome west third quarter conference call issue financial result morning release post investor section company website locate westpharma morning green review financial result provide update business present update full year financial guidance slide presentation accompany today call copy presentation available investor section website slide safe harbor statement statement make management call accompany presentation contain forward look statement within mean federal security statement base belief assumption current expectation estimate forecast company future result influence many factor beyond control company actual result could differ materially past result express imply forward look statement make please refer today press release disclosure make company regard risk subject include report today call management make reference financial measure include organic sale growth adjust operate profit adjust operate profit margin adjust dilute reconciliation limitation financial measure comparable financial result prepare conformity provide morning earn release turn call west president green green chief executive officer thank good morning everyone thank join today start slide deliver incredibly strong third quarter prove market lead strategy deliver double digit growth across three market unit geography exclude positive impact sale relate pandemic deliver double digit growth base business continue strong adoption high value product couple solid execution leverage global operate model lead robust margin expansion growth quarter performance make possible commitment west member across globe business help customer bring medicine treatment improve life patient proud humble live purpose produce billion component device quarter knowledge every component make impact patient life continue fulfill purpose earn customer trust lead quality service science look ahead position right growth strategy commit order book remain robust continue capture benefit globalization operate network continue capital investment support increase demand drive pandemic attractive market substantial momentum raise sale guidance full year consecutive year increase company dividend greater detail shortly turn slide driver growth fuel customer seal include highest level biologic customer shift preference premium platform achieve highest quality tightest specification newly approve biologic drug pharma generic customer increase order demand grow vaccine injectable drug shift device portfolio long stand partnership continue adoption uptick customer interest pipeline drug crystal cartridge vial meet demand stay ahead current growth trend future approval continue manufacture capacity successfully validate additional line insert needle begin produce commercial product year product component contribute grow book commit order position remainder year beyond move slide date leverage global infrastructure agility meet increase customer order highlight several phase investment proceed realize since onset pandemic expand capacity exist site major facility modification dedicate million capital incremental piece equipment keep pace grow base demand move operation book commit order continue surge continue make strategic investment meet demand today announce fourth phase capacity expansion commence primarily focus expand production site unite state shift rapidly change environment impact global supply chain industry immune impact work partner help overcome challenge span transportation logistics material secure labor lead inflation delay successfully navigate environment thank part unsurpassed manufacture footprint continue serve business operate unprecedented time turn slide proud significant progress make priority integral part west culture commitment stakeholder community work live past year continue raise aspect initiative remain track publish year supplement corporate responsibility report incorporate standard turn provide detail financial performance chief financial officer thank good morning review number detail first look revenue profit continue strong sale growth lead strong revenue performance biologics generic pharma market unit take margin growth quarter balance sheet takeaway finally provide update guidance first financial result summarize slide reconciliation measure describe slide record sale million represent organic sale growth relate revenue estimate approximately million quarter revenue include assessment component associate vaccine treatment diagnosis patient offset lower sale customer affect lower volume pandemic look slide proprietary product sale grow organically quarter high value product make approximately proprietary product sale quarter grow double digit solid momentum across market unit look performance market unit biologics market unit deliver strong double digit growth continue work many biotech biopharma customer west high value product offer generic market unit also experience double digit growth lead sale component pharma market unit also strong double digit growth sale lead high value product include component contract manufacture single digit organic sale growth third quarter lead sale healthcare relate medical device continue improvement gross profit record million gross profit million last year gross profit margin basis point expansion period last year improvement adjust operate profit million record quarter compare million period last year increase adjust operate profit margin basis point increase period last year finally adjust dilute grow exclude stock base compensation benefit grow approximately review growth driver revenue profit slide show contribution sale growth quarter volume contribute million percentage point growth include approximately million incremental volume drive relate demand sale price increase contribute million percentage point growth look margin performance slide show consolidate gross profit margin proprietary product third quarter gross profit margin basis point margin achieve third quarter driver continue improvement proprietary product gross profit margin favorable product sell drive growth high value product production efficiency sale price increase partially offset increase overhead inclusive compensation contract manufacture third quarter gross profit margin basis point margin achieve quarter decrease margin largely attribute product sell time material price increase customer look balance sheet takeaway review term generate cash business slide list cash flow metric operate cash flow million third quarter increase million compare period last year increase operate cash flow period adversely impact work capital increase time payment third quarter year date capital spend million million higher period last year work capital approximately billion increase million primarily higher account receivable increase sale cash balance million million higher balance increase cash primarily strong operate result period offset share repurchase program higher capex turn guidance slide provide high level summary full year sale expect range billion billion compare prior guidance range billion billion guidance include estimate coal incremental revenue approximately million estimate benefit million base current foreign exchange rate compare prior estimate benefit million million reduction tailwind absorb guidance expect organic sale growth approximately compare prior range expect full year report dilute guidance range compare prior range revise guidance include positive impact benefit stock base compensation first nine month also capex guidance remain million year element want bring attention review guidance estimate benefit impact approximately base current foreign currency exchange rate compare prior estimate benefit guidance exclude future benefit stock base compensation summarize takeaway third quarter strong line growth proprietary gross profit margin improvement growth operate profit margin growth adjust dilute growth operate cash flow deliver line pillar execute innovate grow like turn call back green chief executive officer great thank summarize slide excellent financial performance report today continue reaffirm strategy work market lead approach deliver unique value customer global operation efficiently manufacture deliver product complex environment focus service quality continue accelerate capital spend across operation meet current anticipate future growth importantly incredible work make happen proud serve valuable trust partner customer support patient health look forward continue play critical role deliver healthcare future ready take question thank